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1. Introduction 
The recognition of environmental information with emotional valence is crucial for the 
adjustment and social functioning. Since Darwin (1872), facial expressions of basic emotions 
have been considered as a fundamental component of the processing of emotions and 
various studies have provided evidence of a dissociable although interconnected 
involvement of different neural substrates in the emotional processing. Happiness, sadness, 
anger, fear and disgust are considered as basic emotions. Although with some controversies, 
surprise is also considered as a basic emotion. 
In spite of some contrary positions (e.g. Russell, 1994) facial expressions of basic emotions 
have been considered as universal, i.e., identified in a similar way in different cultures, 
whether they are literate or preliterate (Andrew, 1963; Ekman et al., 1969), as originally 
proposed by Charles Darwin. The studies carried out by Paul Ekman and his colleagues led 
to the development of a database of photographs of actors and actresses expressing basic 
emotions, called Pictures of Facial Affect (Ekman & Friesen, 1976), which has been widely 
used in different paradigms, such as emotional processing and aversive conditioning and, 
more recently, psychological paradigms of activation associated with functional 
neuroimaging. Other sets of images with facial expressions (Gur et al., 2002) have also been 
used. 
The facial musculature is complex, diverse and highly specialized. From an evolutionary 
perspective, the proliferation and diversification of the facial muscles coincide with the 
development of language and the period of rapid increase in hominid brain size, when they 
left the rain forest to live on the savannah. Life in groups led gains to secure food through 
hunting, and safety from predators. On the other hand, guarantee the survival and breeding 
in large groups required capacity to recognize emotions of other members of the social 
organization and, therefore, predict their behavior. If the social cues are important 
components in this new social organization, the ability to identify and translate these signals 
must have evolved in parallel with the development of the ability to express and manage, at 
least partially, the facial expressions. Therefore, humans would not be able to communicate 
emotional signs, but also to decode them quickly and efficiently (Öhman, 2002).  
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Our innate ability of decoding emotional signs communicated by our peers can be affected 
by several conditions, such emotional state, personality traits, diagnosis of mental disorders, 
drug manipulation, among others. In this chapter we will review results about emotional 
face processing, obtained through different techniques that can bring some information 
about the pathophysiology of anxiety and mood disorders.  
 
2. Neural substrates of emotional faces processing 
The advance of neuroimaging techniques has provided substantial data for the 
understanding of the neurobiology of the emotional processing in humans. Several 
paradigms of psychological activation have been examined by magnetic resonance imaging 
(fMRI) and positron emission tomography (PET) in order to evaluate specific components of 
the processing of emotions, such as the conscious or unconscious identification perception of 
basic emotions, fear conditioning, reward and punishment, among others. Studies of fMRI, 
applying psychological activation paradigms aimed at verifying the neural responses of 
healthy volunteers to facial expressions of basic emotions, suggest the activation of specific 
neural substrates for different emotional expressions.  
The face perception in humans is mediated by a neuronal system consisted by multiple and 
bilateral regions (Haxby et al., 2002). This system has a hierarchical organization, initially 
composed of a system of visual processing of the face, made up of three distinct regions. The 
first of these regions is the inferior occipital gyrus that captures the general features of the 
face perception. This region connects to two other regions, the superior temporal sulcus and 
the fusiform gyrus. The superior temporal sulcus assesses changing aspects of the face, as 
the perception of gaze direction of the face and mouth movements. The lateral fusiform 
gyrus analyzes the invariant aspects of the face, giving the unique identity of each face. This 
system of visual analysis of the face sends links to an extensive neuronal plot with different 
cognitive functions that can act in accordance with the visual analysis system to give 
meaning to the faces. The superior temporal sulcus connects with the intraparietal sulcus, 
responsible for analyzing the spatial direction, related to head movement and direction of 
the eyes, and the auditory cortex responsible for processing phonetic content that 
accompanies the facial stimuli. The fusiform gyrus is connected to the lateral anterior 
temporal gyrus to process information concerning the identity of the person, name and 
biographical information. These regions would be connected with the amygdala, insula and 
other structures of the limbic system.  
The activation of the amygdala to fearful faces has been extensively demonstrated in 
neuroimaging studies with healthy volunteers (Breiter et al., 1996) and studies in patients 
with neurological injuries show that lesions in the amygdala are associated with impairment 
in the recognition of facial expressions of fear (Adolphs et al., 1994). Although it is quite 
significant, the relationship between amygdala activation and the expression of fear seems 
to be unspecific, since it has also been shown activation of this structure to other emotions 
such as anger (Hariri et al., 2000), disgust (Sprengelmeyer et al., 1998), sadness (Surguladze 
et al., 2003), happiness (Breiter et al., 1996; Surguladze et al., 2003) and surprise, when this 
was interpreted negatively (Kim et al., 2003), suggesting a wider role of the amygdala in 
different stimuli with emotional valence.  
The amygdala seems also to be involved in unconscious emotional processes, because 
neuronal responses has been observed in this area even when the volunteers did not have an 
explicit recognition of emotional expressions (Whalen et al., 1998). Moreover, the activation 
of the amygdala to negative facial expressions presented in an unconscious perception 
paradigm (stimulus presentation for 33 milliseconds, followed by a neutral face, with a 
duration of 333 milliseconds) was followed by a bias for negative evaluation of the faces in a 
behavioral paradigm similar to that presented in the scanner (Dannlowski et al., 2007). 
These findings suggest that the increase in the neuronal activation of the amygdala would 
correlate with increased identification of emotion.  
The processing of facial expressions of disgust has been consistently associated with 
activations in the insular cortex (Phillips et al., 1997), although negative results and 
activation of the insula by other emotions such as anger have also been reported. In 
addition, patients with Huntington's disease has an impairment in the recognition of 
emotional expressions of disgust (Sprengelmeyer et al., 1996), suggesting that fronto-striatal 
and especially the basal ganglia are also involved in the recognition of facial expressions of 
disgust, as these regions are involved in Huntington's disease.  
Angry faces can be considered as a guide for the others’ behavior, in situations where social 
rules or expectations are violated (Averill, 1982). The orbitofrontal cortex is crucially 
involved in this kind of function and activations in this region to expressions of anger are 
reported (Sprengelmeyer et al., 1998). Additionally, patients with lesions in orbitofrontal 
cortex, who began to show sociopathic behavior, show a generalized impairment in the 
recognition of facial expressions, but with a more pronounced impairment in the recognition 
of faces of anger (Blair, 2003) .  
Activations of the frontal cortex and the cingulate cortex during the recognition of various 
facial expressions can be associated with the function of these regions in cognitive and 
integrative processing of emotions (Lane et al., 1998).  
The processing of facial expressions is predominantly involved in identifying emotions, but 
there is evidence suggesting that viewing of facial expressions would also be able to evoke 
emotions through a more primitive emotional contagion (Wild et al., 2001). An alternative to 
the study of  evoked emotions is the use of scenes depicting situations which could lead to 
subjective emotional states, such as the database developed by Lang and his colleagues 
(Lang et al., 1993), called the International Affective Picture System (IAPS). Hundreds of 
scenes constituents of this database were evaluated for the valence and the arousal during 
the validation process. In a study (Britton et al., 2006) comparing the neuronal activation 
caused by facial expressions of happiness, sadness, fear and anger with the neuronal 
activation caused by viewing of IAPS pictures with the same emotional content, it has been 
shown that both stimuli activated brain areas in common, such as the amygdala, posterior 
hippocampus, prefrontal cortex and medial visual cortex. Moreover, activations in anterior 
cingulate, insula and superior temporal gyrus were more pronounced for faces than to 
scenes. In this study it was found that the agreement on the definition of emotion displayed 
by the stimulus was greater for faces than for scenes, although the later were rated as with 
greater valence and arousal than the former. A limitation for the use of scenes would be the 
complexity and amount of information in each picture, which could lead to the recruitment 
of additional cognitive processing, and recall of prior personal experiences. On the other 
hand, habituation would be less frequent with the scenes compared to faces.  
The neuroimaging findings indicate the existence of specific neural substrates related to the 
recognition of facial expressions of basic emotions. A meta-analysis (Phan et al., 2002) 
suggested that the amygdala plays a key role in processing emotions of fear, while the basal 
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ganglia seem to be particularly involved in processing other emotions such as disgust and 
happiness. Specifically in regard to the processing of emotional faces, a recent review of 105 
fMRI studies with healthy volunteers (Fusar-Poli et al., 2009) has shown activation of 
amygdala to fearful, happy and sad faces, with a greater sensitivity of the amygdala for fear 
than happiness or sadness. On the other hand, insular response was observed to angry and 
disgusted faces, with a greater sensitivity to disgust than to anger. The former meta-analysis 
also demonstrated that regions of cortex medial prefrontal cortex (areas 9 and 10 of 
Brodman) extending to the anterior cingulate gyrus (areas 32/33 and 24 of Brodman) are 
commonly activated by different emotions, strengthening the involvement of these 
structures in the cognitive aspects of processing of emotions. 
Since a considerable body of evidence points to sex differences in the emotional processing 
(Cahill, 2006), the sexual polymorphism can be a confounding variable in studies looking at 
the processing of facial expression. Considering the relevance of sex differences in emotional 
processing, it will be discussed separately. 
 
3. Sexual dimorphism in emotional faces processing  
There is a consistent body of evidence of sex differences in the performance of cognitive and 
emotional functions. In short, women seem to perform better on tasks of verbal fluency, 
memory and fine motor tasks, while men perform better on tasks related to math and spatial 
skills (Halpern, 1992). Despite the evidence of sex differences on the cognitive and emotional 
processes, this issue is still quite controversial and the magnitude, extent and nature of these 
differences are not fully understood.   
Regarding the processing of facial expressions, the results are even more inconsistent. The 
results of studies comparing the performance of healthy men and women in the 
identification of basic emotions in facial expressions are controversial, with many pointing 
to negative results (e.g. Hall et al., 2004), while others point to a difference between the 
sexes. Among the latter, most of them suggest a better performance of women in the 
identification of facial expressions, regardless of emotion evaluated (e.g. Hall and 
Matsumoto, 2004; Rahman et al., 2004; Terracciano et al., 2003). In this direction, 
physiological parameters suggest a greater responsiveness of women to facial expressions 
(Campanella et al., 2004; Dimberg, 1990; Orozco & Ehlers, 1998), although negative results 
have also been reported (Lundqvist, 1995). There are, however, contrary results, showing 
that men would be faster than women to recognize faces of fear (Campanella et al., 2004) 
and anger (Williams & Mattingley, 2006).  
There is also evidence of sex differences in brain lateralization for the processing of 
emotions. In general, men use more right hemisphere when processing facial expressions, 
whereas women use both hemispheres (e.g. Bourne, 2005). Functional neuroimaging studies 
also suggest a sex difference in the processing of facial expressions (McClure et al., 2004; 
Williams et al., 2005) and seems to confirm the findings of behavioral lateralization 
described above. There are, however, reported negative results (Schroeder et al., 2004).  
Although neuroimaging studies point to sex differences in neuronal activation caused by 
emotional faces, results are quite variable, preventing the establishment of a pattern which 
distinguishes one kind or another. For instance, men showed more pronounced activation of 
left amygdala in one study (Killgore & Yurgelun-Todd, 2001) but of the right amygdala in 
other (Williams et al., 2005) to fearful faces. It has also been reported greater activation in 
right insula and decreased activation in bilateral hippocampus in men during exposure to 
faces of fear (Williams et al., 2005). Differences in activation of the anterior cingulate cortex 
are also controversial, with one study showing activation more pronounced in males 
(McClure et al., 2004) and another study showing higher activation in females (Williams et 
al., 2005). There is evidence, however, of an interaction between sex of face and sex of the 
observer in regard to the activations of the anterior cingulate cortex. Men had a more 
pronounced activation in this region when looking at male faces, whereas women had more 
pronounced activations viewing female faces (Fischer et al., 2004). Finally, women had 
greater hemodynamic responses in the amygdala and right frontal regions to the angry faces 
(McClure et al., 2004) and men showed more pronounced activation of right amygdala to 
happy faces (Killgore and Yurgelun-Todd, 2001). 
Taken together, the behavioral, physiological and neuroimaging data obtained so far 
indicate a sexual dimorphism in the processing of facial expressions, although the 
performance data in the paradigms are less consistent.  
The difference in the behavioral data may be related to the lack of control of the phase of the 
menstrual cycle. There is evidence from cognitive studies pointing to a fluctuating response 
pattern, related to the phases of the menstrual cycle (Maki et al., 2002). In regard to 
emotional faces, it has also been shown that women identified facial expressions of fear with 
greater accuracy during the menstrual cycle characterized by high levels of estrogen 
(Pearson and Lewis, 2005). In addition, higher levels of progesterone have been associated to 
a better accuracy in the identification of fearful and disgusted faces with averted gaze as 
more intense than those with direct gaze (Conway et al., 2007). However, conflicting results 
have also been reported: women in the follicular phase, characterized by lower levels of 
progesterone, were more accurate in identifying all emotions than women in luteal phase, 
characterized by higher levels of progesterone. The behavioral performance was associated 
to stronger amygdalar activation to emotional faces, measured through functional magnetic 
resonance imaging (fMRI), with a negative correlation between plasma level of progesterone 
and amygdalar response to fearful, sad and neutral faces (Derntl et al., 2008a; Derntl et al., 
2008b). Recently, we have shown that healthy women in the early follicular phase (day 1 to 5 
of the menstrual cycle) recognized angry faces more precisely than women in the ovulatory 
phase (days 12 to 14) or women in the luteal phase (days 21 to 23). Sadness was more 
accurately recognized by women in the early follicular phase than by women in the luteal 
phase. Blood levels of estrogen were negatively correlated to the accuracy in identification 
of angry faces (Guapo et al., 2009).  
Overall, the results of the studies carried out so far support the idea that women process 
facial expressions more efficiently than men. The results of accuracy in the tasks of 
identifying emotions are supported by physiological measures. For example, women had 
EEG (Campanella et al., 2004; Orozco and Ehlers, 1998) and EMG (Dimberg, 1990; 
Lundqvist, 1995) responses more pronounced, reinforcing the hypothesis that women pay 
more attention and have somatic reactions more intensively to emotional faces. In addition, 
women take into account the emotion evoked and emotional valence of the stimulus to 
evaluate facial expressions, while men consider only the valence component (Thayer and 
Johnsen, 2000). Evidence from the neuroimaging studies suggest that men and women use 
different neural networks for the processing of emotions, reinforcing the hypothesis of 
different strategies for the identification of emotions.  
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Despite the evidence of sex differences in brain function, this variable is rarely controlled in 
neuroscience research aimed at the cognitive and emotional processes, both normal and 
pathological (Cahill, 2006). Many mental disorders have a clear sex differences in the 
prevalence, clinical presentation and response to treatment, making vital controlling this 
confounding variable in future studies. The prevalence of depression and anxiety disorders 
is two times higher in women than in men (Kessler et al., 1993; Weissman et al., 1996). 
However, little attention has been paid to possible sex differences in emotional and 
cognitive mechanisms involved in the development and maintenance of depressive and 
anxious symptoms. 
 
4. Anxiety, depression and emotional faces processing 
There is evidence that in healthy subjects, some personality traits, which may represent an 
increased risk for developing depressive or anxiety disorders, may interfere with the 
processing of facial expressions. The predisposition to react with more anxiety as measured 
by the trait form of the Trait Anxiety Inventory-State (STAI) (Spielberger, 1983), was 
associated with a greater accuracy in identifying facial expressions of fear without 
interfering with the recognition of other facial expressions (Surcinelli et al., 2006). High 
scores on the Neuroticism subscale of the Personality Questionnaire developed by Hans 
Eysenck and colleagues have been considered as a vulnerability factor for the occurrence of 
depression (revised in Christensen & Kessing, 2006. Healthy subjects of both sexes with high 
scores on the subscale of Neuroticism were less accurate than individuals with low subscale 
scores in identifying happy faces (Chan et al., 2007).  
Physiological measures also confirm changes in processing of faces of fear in anxious 
individuals (Rossignol et al., 2005). For example, healthy women with high levels of fear of 
public speaking had a higher sensitivity to angry faces, as measured by contraction of the 
corrugator muscles, and to happy faces, as measured by contraction of the zygomaticus, and 
also attributed a more negative valence the faces of anger than women with low fear of 
public speaking (Dimberg and Thunberg, 2007). Although dysfunctions of the 
hypothalamic-pituitary-adrenal axis have been reported in patients with depression and 
anxiety, there is evidence that acutely, glucocorticoids may reduce fear reactions. Acute 
administration of 40 mg of cortisol attenuated the unconscious perception of facial 
expressions of fear, particularly in individuals who self-reported themselves as anxious 
(Putman et al., 2007).  
Neuroimaging studies point to a hyperactivity of the amygdala to expressions of fear in 
individuals with higher levels of anxiety, measured through the scores on the STAI-T (Etkin 
et al., 2004). Healthy individuals prone to anxiety showed more pronounced activation of 
the amygdala and insula to faces of anger, fear and happiness compared to a sensorimotor 
task, than subjects with low propensity to anxiety. No differences were found between the 
activation caused by each emotion separately (Stein et al., 2007). There is also evidence of an 
association between the expression of the short allele of the serotonin transporter, which has 
been associated to a higher risk to depression and anxiety, and hyperreactivity of the 
amygdala to faces of fear and anger in healthy volunteers of both sexes (Hariri et al., 2002).  
Among patients with established diagnosis of anxiety disorders, there is also evidence of 
impaired processing of facial expressions. Patients with social phobia had higher skin 
conductance response than healthy volunteers to fearful faces presented subliminally  
(Tsunoda et al., 2008). Functional neuroimaging studies have shown that no medicated 
social phobics patients had more pronounced activation of the amygdala to aversive faces 
(anger, fear, disgust) compared with faces of happiness, than healthy volunteers, and that 
the intensity of the hemodynamic response correlated with the severity of the phobic 
symptoms (Phan et al., 2006).  
Panic disorder without agoraphobia or other comorbidities had an impaired of the 
identification of facial expressions, particularly the emotions of sadness and anger, in 
comparison to matched healthy controls. Patients also showed a tendency to mistakenly 
identify other expressions as anger. However, the presence of depressive symptoms 
correlated with the performance on the task and the difference between patients and 
controls disappeared when controlled for depression (Kessler et al., 2007). On the other 
hand, patients diagnosed with panic disorder and homozygous for the 1019G risk allele of 
the serotonin receptor 5-HT1A type showed more pronounced activation of the amygdala to 
faces of happiness and attenuation of the activation of prefrontal regions to fearful faces. The 
same pattern of increased amygdala activation to happy faces was observed in patients 
carrying the short allele of the serotonin transporter (Domschke et al., 2006).  
Compared with healthy controls, panic patients showed lower intensity of the BOLD (Blood 
Oxygen Level Dependent) signal in the anterior cingulate cortex and amygdala than healthy 
controls in response to faces of fear and activations of the cingulate cortex were negatively 
correlated with subjective measures of anxiety (Pillay et al., 2006). This same group 
demonstrated that in response to faces of happiness, patients with panic disorder showed 
more pronounced activation of the anterior cingulate cortex, with no differences between 
groups in amygdalar activations (Pillay et al., 2007).  
Some interesting results about emotional processing in patients with anxiety disorder come 
from a meta-analysis (Etkin & Wager, 2007) aimed at evaluating the functional 
neuroimaging studies of patients who underwent paradigms characterized by the contrast 
of negative emotional stimuli with positive or neutral conditions. They included studies 
with several paradigms and stimuli such as fear of public speaking for social phobia, 
memory of traumatic events in posttraumatic stress disorder and presentation of phobic 
stimuli in specific phobia. The processing of facial expressions was assessed in all anxiety 
disorders. However, panic disorder and obsessive-compulsive disorder were not included 
in the meta-analysis because the studies conducted so far have not fulfilled the inclusion 
criteria established by the authors. Activation of the amygdala and insula to negative stimuli 
were found in the three disorders studied, suggesting a common involvement of these 
structures in the pathophysiology of these disorders. Hyperactivity of the amygdala and the 
insula was more frequently observed in social phobia and specific phobia than in 
posttraumatic stress disorder, which in turn, presented reduced activations in the 
ventromedial prefrontal cortex, cingulate cortex and thalamus, which was not observed in 
other mental disorders study.  
Cognitive theories tend to imply negative interpretations in the psychopathology of 
depression. Depressed individuals, or individuals predisposed to depression, have a 
tendency to evaluate themselves, others and events of everyday life in a more negative way 
than healthy controls (Beck, 1979). Patients diagnosed with major depression tend to 
perceive negative emotional stimuli, including faces of sadness, with greater frequency or 
accuracy than healthy controls, and tend to pay less attention to positive stimuli, such as 
happy faces. Some of these abnormalities persist after remission of symptoms and are also 
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Despite the evidence of sex differences in brain function, this variable is rarely controlled in 
neuroscience research aimed at the cognitive and emotional processes, both normal and 
pathological (Cahill, 2006). Many mental disorders have a clear sex differences in the 
prevalence, clinical presentation and response to treatment, making vital controlling this 
confounding variable in future studies. The prevalence of depression and anxiety disorders 
is two times higher in women than in men (Kessler et al., 1993; Weissman et al., 1996). 
However, little attention has been paid to possible sex differences in emotional and 
cognitive mechanisms involved in the development and maintenance of depressive and 
anxious symptoms. 
 
4. Anxiety, depression and emotional faces processing 
There is evidence that in healthy subjects, some personality traits, which may represent an 
increased risk for developing depressive or anxiety disorders, may interfere with the 
processing of facial expressions. The predisposition to react with more anxiety as measured 
by the trait form of the Trait Anxiety Inventory-State (STAI) (Spielberger, 1983), was 
associated with a greater accuracy in identifying facial expressions of fear without 
interfering with the recognition of other facial expressions (Surcinelli et al., 2006). High 
scores on the Neuroticism subscale of the Personality Questionnaire developed by Hans 
Eysenck and colleagues have been considered as a vulnerability factor for the occurrence of 
depression (revised in Christensen & Kessing, 2006. Healthy subjects of both sexes with high 
scores on the subscale of Neuroticism were less accurate than individuals with low subscale 
scores in identifying happy faces (Chan et al., 2007).  
Physiological measures also confirm changes in processing of faces of fear in anxious 
individuals (Rossignol et al., 2005). For example, healthy women with high levels of fear of 
public speaking had a higher sensitivity to angry faces, as measured by contraction of the 
corrugator muscles, and to happy faces, as measured by contraction of the zygomaticus, and 
also attributed a more negative valence the faces of anger than women with low fear of 
public speaking (Dimberg and Thunberg, 2007). Although dysfunctions of the 
hypothalamic-pituitary-adrenal axis have been reported in patients with depression and 
anxiety, there is evidence that acutely, glucocorticoids may reduce fear reactions. Acute 
administration of 40 mg of cortisol attenuated the unconscious perception of facial 
expressions of fear, particularly in individuals who self-reported themselves as anxious 
(Putman et al., 2007).  
Neuroimaging studies point to a hyperactivity of the amygdala to expressions of fear in 
individuals with higher levels of anxiety, measured through the scores on the STAI-T (Etkin 
et al., 2004). Healthy individuals prone to anxiety showed more pronounced activation of 
the amygdala and insula to faces of anger, fear and happiness compared to a sensorimotor 
task, than subjects with low propensity to anxiety. No differences were found between the 
activation caused by each emotion separately (Stein et al., 2007). There is also evidence of an 
association between the expression of the short allele of the serotonin transporter, which has 
been associated to a higher risk to depression and anxiety, and hyperreactivity of the 
amygdala to faces of fear and anger in healthy volunteers of both sexes (Hariri et al., 2002).  
Among patients with established diagnosis of anxiety disorders, there is also evidence of 
impaired processing of facial expressions. Patients with social phobia had higher skin 
conductance response than healthy volunteers to fearful faces presented subliminally  
(Tsunoda et al., 2008). Functional neuroimaging studies have shown that no medicated 
social phobics patients had more pronounced activation of the amygdala to aversive faces 
(anger, fear, disgust) compared with faces of happiness, than healthy volunteers, and that 
the intensity of the hemodynamic response correlated with the severity of the phobic 
symptoms (Phan et al., 2006).  
Panic disorder without agoraphobia or other comorbidities had an impaired of the 
identification of facial expressions, particularly the emotions of sadness and anger, in 
comparison to matched healthy controls. Patients also showed a tendency to mistakenly 
identify other expressions as anger. However, the presence of depressive symptoms 
correlated with the performance on the task and the difference between patients and 
controls disappeared when controlled for depression (Kessler et al., 2007). On the other 
hand, patients diagnosed with panic disorder and homozygous for the 1019G risk allele of 
the serotonin receptor 5-HT1A type showed more pronounced activation of the amygdala to 
faces of happiness and attenuation of the activation of prefrontal regions to fearful faces. The 
same pattern of increased amygdala activation to happy faces was observed in patients 
carrying the short allele of the serotonin transporter (Domschke et al., 2006).  
Compared with healthy controls, panic patients showed lower intensity of the BOLD (Blood 
Oxygen Level Dependent) signal in the anterior cingulate cortex and amygdala than healthy 
controls in response to faces of fear and activations of the cingulate cortex were negatively 
correlated with subjective measures of anxiety (Pillay et al., 2006). This same group 
demonstrated that in response to faces of happiness, patients with panic disorder showed 
more pronounced activation of the anterior cingulate cortex, with no differences between 
groups in amygdalar activations (Pillay et al., 2007).  
Some interesting results about emotional processing in patients with anxiety disorder come 
from a meta-analysis (Etkin & Wager, 2007) aimed at evaluating the functional 
neuroimaging studies of patients who underwent paradigms characterized by the contrast 
of negative emotional stimuli with positive or neutral conditions. They included studies 
with several paradigms and stimuli such as fear of public speaking for social phobia, 
memory of traumatic events in posttraumatic stress disorder and presentation of phobic 
stimuli in specific phobia. The processing of facial expressions was assessed in all anxiety 
disorders. However, panic disorder and obsessive-compulsive disorder were not included 
in the meta-analysis because the studies conducted so far have not fulfilled the inclusion 
criteria established by the authors. Activation of the amygdala and insula to negative stimuli 
were found in the three disorders studied, suggesting a common involvement of these 
structures in the pathophysiology of these disorders. Hyperactivity of the amygdala and the 
insula was more frequently observed in social phobia and specific phobia than in 
posttraumatic stress disorder, which in turn, presented reduced activations in the 
ventromedial prefrontal cortex, cingulate cortex and thalamus, which was not observed in 
other mental disorders study.  
Cognitive theories tend to imply negative interpretations in the psychopathology of 
depression. Depressed individuals, or individuals predisposed to depression, have a 
tendency to evaluate themselves, others and events of everyday life in a more negative way 
than healthy controls (Beck, 1979). Patients diagnosed with major depression tend to 
perceive negative emotional stimuli, including faces of sadness, with greater frequency or 
accuracy than healthy controls, and tend to pay less attention to positive stimuli, such as 
happy faces. Some of these abnormalities persist after remission of symptoms and are also 
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found in non-depressed persons with a high risk of developing depression (revised in 
Leppanen, 2006).  
Depressed subjects had a negative bias in judging facial expressions (Gur et al., 1992), 
particularly the emotion of sadness, with a strong correlation with the severity of depressive 
symptoms (Hale, 1998). In addition, the bias for the judgment of ambiguous facial 
expressions as sadness seems to be a predictor of the persistence of depressive symptoms 
(Hale, 1998), particularly in women (Bouhuys et al., 1999). Patients in complete remission 
from depression had a selective attention to facial expressions of sadness, similar to patients 
with current depression, while healthy volunteers tend to avoid the sad faces and oriented 
themselves to faces of happiness (Joormann and Gotlib, 2007). Furthermore, the recognition 
of facial expressions of fear and higher levels of urinary cortisol in depressed patients in 
complete remission were predictive of the occurrence of relapse (Bouhuys et al., 2006).  
Increased neural activity to negative stimuli and decreased neural activity for positive 
stimuli in brain regions related to the processing of emotions, such as the amygdala and 
ventral striatum have also been reported in depressed patients (Leppanen, 2006). Depressed 
patients showed more pronounced activation of the amygdala and ventral striatum to faces 
of sadness (Fu et al., 2004) and an attenuated response to faces of happiness in the regions of 
putamen, hippocampus and ventral striatum compared with healthy controls (Fu et al., 
2007). Chronic treatment with antidepressants normalized brain activation, attenuating the 
neuronal response of the left amygdala and ventral striatum to faces of sadness (Fu et al., 
2004) and increasing the response of the ventral striatum to faces of happiness (Fu et al., 
2007).  
There is also evidence of an association between structural brain changes and emotional 
faces processing in depressed patients. Individuals diagnosed with major depression 
showed increased amygdalar volume and reduced hippocampal volume compared to 
controls, in addition to deficits in learning emotional faces, especially with emotions of fear, 
surprise and disgust. The size of amygdala correlated with the impairment in task 
performance and presence of symptoms of anxiety. The size of the hippocampus also 
correlated with the presence of symptoms of anxiety (Weniger et al., 2006).  
Taken together, the studies with patients with depression and anxiety disorders suggest 
impairment in processing facial expressions of basic emotions. Among anxiety disorders, it 
has been observed a tendency for greater recognition of negative expressions, especially fear 
and anger, while in the depressive disorders there is a loss of the recognition of positive 
expressions and increased recognition of negative expressions, with emphasis in sad faces.  
In general, neuroimaging studies indicate greater hemodynamic responses in patients than 
in healthy controls the presentation of facial expressions of basic emotions. The amygdala 
has been particularly involved in the pathophysiology of depression and anxiety disorders, 
and changes in their activation to emotional faces have been found in most studies with 
psychiatric patients. 
 
5. Pharmacological modulation of emotional faces processing 
Other evidence pointing to the existence of distinct neurocognitive systems in the emotional 
processing come from studies that evaluate the effects of psychoactive drugs in the 
perception of emotional expressions. Pharmacological challenges that interfere with various 
neurotransmitter systems have been used for the evaluation of their role in identifying facial 
expressions, particularly with drugs that act on the serotonergic and GABAergic systems, 
which will be detailed below.  
 
5.1 Modulation by the serotonergic system  
The results of pharmacological challenges that interfere with serotonin function reinforce 
the role of serotonin (5-HT) in the processing of anxiety and fear (Deakin and Graeff, 1991), 
and behavioral effects were observed mainly on the recognition of facial expression of fear. 
Other emotions such as happiness and disgust, also seem to suffer interference in the 
serotonin levels for processing, though less consistent across studies. 
These studies (for review, see Del-Ben et al., 2008) have shown that decreased serotonin 
function through depletion of the supply of tryptophan in the diet reduced the recognition 
of facial expressions of fear in women, and in individuals of both sexes carrying the short 
allele of the serotonin transporter. On the other hand, the acute increase in the dietary intake 
of tryptophan increased the recognition of expressions of happiness and fear in female 
volunteers; supplementation of tryptophan for 14 days facilitated the identification of facial 
expressions of happiness and decreased the recognition of expressions of disgust in women 
but not in male subjects.  
The acute administration of intravenous citalopram, a selective inhibitor of serotonin 
reuptake inhibitor (SSRI), facilitated the recognition of expressions of happiness and fear in 
women. A similar effect on faces of fear was obtained after a single dose of citalopram 
administered orally in healthy volunteers of both sexes. In contrast, the administration for 7 
days of oral citalopram (20 mg daily) in healthy volunteers of both sexes has increased the 
recognition of facial expressions of anger, fear and disgust, compared with the volunteers 
treated with placebo. A later study from the same group confirmed the reduction of the 
identification of fearful faces after treatment for 7 days with citalopram (20 mg daily) in both 
sexes. Euthymic patients with a history of major depression recognized fearful faces more 
precisely than healthy controls. The acute administration of intravenous citalopram 
normalized to recognition of expressions of fear in women with a history of depression, but 
increased the recognition of facial expressions of fear in women with no past history of 
depression.  
These studies also suggest a sexual dimorphism in serotonergic modulation of the 
perception of facial expressions, since the effects of manipulating serotonin were found 
mainly in female volunteers. However, it is impossible to explore this hypothesis more 
deeply, since several studies included only women in their sample. 
Acute administration of 3,4-Metilenedioximetamfetamina (MDMA, "ecstasy") in volunteers 
of both sexes led to an increased recognition of expressions of fear, while in the fourth day 
of abstinence was observed opposite effect. The drug did not interfere in the recognition of 
other emotional expressions. Although MDMA causes release of dopamine and 
norepinephrine, its main mechanism of action is via the serotonergic system, by inhibiting 
the reuptake of serotonin available in the synaptic cleft and the stimulation of the release of 
serotonin stored in presynaptic vesicles. In addition, MDMA decreases the synthesis of 
serotonin by inhibiting the activity of the enzyme tryptophan hydroxylase, leading to a 
depletion of brain serotonin in the subsequent days of substance use. The acute effect of 
"ecstasy" facilitated the recognition of facial expressions of fear, but impaired the recognition 
of facial expressions, four days after use, suggesting that increased 5-HT function facilitates 
the recognition, while the reduction of 5-HT function enables the perception of facial 
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found in non-depressed persons with a high risk of developing depression (revised in 
Leppanen, 2006).  
Depressed subjects had a negative bias in judging facial expressions (Gur et al., 1992), 
particularly the emotion of sadness, with a strong correlation with the severity of depressive 
symptoms (Hale, 1998). In addition, the bias for the judgment of ambiguous facial 
expressions as sadness seems to be a predictor of the persistence of depressive symptoms 
(Hale, 1998), particularly in women (Bouhuys et al., 1999). Patients in complete remission 
from depression had a selective attention to facial expressions of sadness, similar to patients 
with current depression, while healthy volunteers tend to avoid the sad faces and oriented 
themselves to faces of happiness (Joormann and Gotlib, 2007). Furthermore, the recognition 
of facial expressions of fear and higher levels of urinary cortisol in depressed patients in 
complete remission were predictive of the occurrence of relapse (Bouhuys et al., 2006).  
Increased neural activity to negative stimuli and decreased neural activity for positive 
stimuli in brain regions related to the processing of emotions, such as the amygdala and 
ventral striatum have also been reported in depressed patients (Leppanen, 2006). Depressed 
patients showed more pronounced activation of the amygdala and ventral striatum to faces 
of sadness (Fu et al., 2004) and an attenuated response to faces of happiness in the regions of 
putamen, hippocampus and ventral striatum compared with healthy controls (Fu et al., 
2007). Chronic treatment with antidepressants normalized brain activation, attenuating the 
neuronal response of the left amygdala and ventral striatum to faces of sadness (Fu et al., 
2004) and increasing the response of the ventral striatum to faces of happiness (Fu et al., 
2007).  
There is also evidence of an association between structural brain changes and emotional 
faces processing in depressed patients. Individuals diagnosed with major depression 
showed increased amygdalar volume and reduced hippocampal volume compared to 
controls, in addition to deficits in learning emotional faces, especially with emotions of fear, 
surprise and disgust. The size of amygdala correlated with the impairment in task 
performance and presence of symptoms of anxiety. The size of the hippocampus also 
correlated with the presence of symptoms of anxiety (Weniger et al., 2006).  
Taken together, the studies with patients with depression and anxiety disorders suggest 
impairment in processing facial expressions of basic emotions. Among anxiety disorders, it 
has been observed a tendency for greater recognition of negative expressions, especially fear 
and anger, while in the depressive disorders there is a loss of the recognition of positive 
expressions and increased recognition of negative expressions, with emphasis in sad faces.  
In general, neuroimaging studies indicate greater hemodynamic responses in patients than 
in healthy controls the presentation of facial expressions of basic emotions. The amygdala 
has been particularly involved in the pathophysiology of depression and anxiety disorders, 
and changes in their activation to emotional faces have been found in most studies with 
psychiatric patients. 
 
5. Pharmacological modulation of emotional faces processing 
Other evidence pointing to the existence of distinct neurocognitive systems in the emotional 
processing come from studies that evaluate the effects of psychoactive drugs in the 
perception of emotional expressions. Pharmacological challenges that interfere with various 
neurotransmitter systems have been used for the evaluation of their role in identifying facial 
expressions, particularly with drugs that act on the serotonergic and GABAergic systems, 
which will be detailed below.  
 
5.1 Modulation by the serotonergic system  
The results of pharmacological challenges that interfere with serotonin function reinforce 
the role of serotonin (5-HT) in the processing of anxiety and fear (Deakin and Graeff, 1991), 
and behavioral effects were observed mainly on the recognition of facial expression of fear. 
Other emotions such as happiness and disgust, also seem to suffer interference in the 
serotonin levels for processing, though less consistent across studies. 
These studies (for review, see Del-Ben et al., 2008) have shown that decreased serotonin 
function through depletion of the supply of tryptophan in the diet reduced the recognition 
of facial expressions of fear in women, and in individuals of both sexes carrying the short 
allele of the serotonin transporter. On the other hand, the acute increase in the dietary intake 
of tryptophan increased the recognition of expressions of happiness and fear in female 
volunteers; supplementation of tryptophan for 14 days facilitated the identification of facial 
expressions of happiness and decreased the recognition of expressions of disgust in women 
but not in male subjects.  
The acute administration of intravenous citalopram, a selective inhibitor of serotonin 
reuptake inhibitor (SSRI), facilitated the recognition of expressions of happiness and fear in 
women. A similar effect on faces of fear was obtained after a single dose of citalopram 
administered orally in healthy volunteers of both sexes. In contrast, the administration for 7 
days of oral citalopram (20 mg daily) in healthy volunteers of both sexes has increased the 
recognition of facial expressions of anger, fear and disgust, compared with the volunteers 
treated with placebo. A later study from the same group confirmed the reduction of the 
identification of fearful faces after treatment for 7 days with citalopram (20 mg daily) in both 
sexes. Euthymic patients with a history of major depression recognized fearful faces more 
precisely than healthy controls. The acute administration of intravenous citalopram 
normalized to recognition of expressions of fear in women with a history of depression, but 
increased the recognition of facial expressions of fear in women with no past history of 
depression.  
These studies also suggest a sexual dimorphism in serotonergic modulation of the 
perception of facial expressions, since the effects of manipulating serotonin were found 
mainly in female volunteers. However, it is impossible to explore this hypothesis more 
deeply, since several studies included only women in their sample. 
Acute administration of 3,4-Metilenedioximetamfetamina (MDMA, "ecstasy") in volunteers 
of both sexes led to an increased recognition of expressions of fear, while in the fourth day 
of abstinence was observed opposite effect. The drug did not interfere in the recognition of 
other emotional expressions. Although MDMA causes release of dopamine and 
norepinephrine, its main mechanism of action is via the serotonergic system, by inhibiting 
the reuptake of serotonin available in the synaptic cleft and the stimulation of the release of 
serotonin stored in presynaptic vesicles. In addition, MDMA decreases the synthesis of 
serotonin by inhibiting the activity of the enzyme tryptophan hydroxylase, leading to a 
depletion of brain serotonin in the subsequent days of substance use. The acute effect of 
"ecstasy" facilitated the recognition of facial expressions of fear, but impaired the recognition 
of facial expressions, four days after use, suggesting that increased 5-HT function facilitates 
the recognition, while the reduction of 5-HT function enables the perception of facial 
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expressions of fear. Challenges with tryptophan point to the same direction, at least in 
female subjects. Dietary supplementation of tryptophan, and consequent increased 
availability of serotonin, facilitated the recognition of facial expressions of fear, while 
tryptophan depletion impaired the recognition of facial expressions of fear. Acute 
administration of citalopram facilitated the recognition of facial expressions of fear, an effect 
similar to those observed with the supplementation of tryptophan in the diet and the acute 
use of ecstasy and opposite to that observed with the depletion of tryptophan and four days 
after the use of ecstasy. Taken together, these data suggest an increase in serotonin function 
immediately after the acute administration of citalopram.  
However, in a recent published study (Alves-Neto et al., 2010), we have found a 
“depressive” effect of a single dose of escitalopram, the pharmacologically active S-
enantiomer of RS-citalopram. The R-enantiomer has been shown to reduce the effects of the 
S-enantiomer (Sanchez, 2006), probably due to negative allosteric interaction at the level of 
the 5-HT transporter. As result, escitalopram behaves as a highly potent and selective ligand 
of the 5-HT transporter and clinical studies have shown that escitalopram causes few side 
effects and has a relatively fast onset of action (Waugh & Goa, 2003). In a placebo controlled 
crossover design study with healthy male volunteers we have found that a single dose of 
escitalopram facilitated the recognition of sadness and inhibited the recognition of 
happiness, but just when viewing male faces. 
The interpretation of the effects of acute administration of SSRIs is not simple, since the 
clinical response to SSRIs is associated with an increase of the serotonin function, which in 
turn depends on an accommodation of serotonin receptors, particularly a desensitization of 
presynaptic receptors type 5-HT1A, which occurs after the use of medication for an average 
of two weeks. It is, therefore, that early treatment with SSRIs would be a reduction of 5-HT 
function, which can be associated, with the worsening of symptoms commonly seen in 
patients with anxiety disorders (Kent et al., 1998). Experimental data showed that after acute 
administration of SSRIs, there is an increase of serotonin in the raphe nuclei that is higher 
than in cortex (Bel & Artigas, 1992). Therefore, the acute administration of SSRI preferably 
would increase the concentration of serotonin around the cell bodies of serotonergic 
neurons, reducing their shots due to the activation of somatodendritics autoreceptors 
(Gartside et al., 1995), which would lead to a reduction in the post-synaptic serotonin levels. 
However, microdialysis studies in animals showed increased concentrations of serotonin in 
the extracellular space in cortical regions after acute administration of SSRI (David et al., 
2003). Furthermore, the acute administration of citalopram in healthy volunteers resulted in 
increased plasma levels of prolactin and cortisol (Attenburrow et al., 2001; McKie et al., 
2005), which is considered as an indirect measure of increased levels of serotonin in the 
central nervous system.  
A possible explanation for these apparently contradictory results comes from studies of the 
functional neuroanatomy of the serotonergic system. These studies have shown that 
anatomically distinct serotoninergic pathways differently modulate specific brain circuits. 
These dissociations suggest that serotonin activity within different regions of the raphe 
nucleus may be under the influence of different regulatory pathways, being recruited in 
different ways, depending on specific conditions of the environment and the characteristics 
of the stimulus (Lowry et al., 2005).  
   
5.2 Modulation of the GABAergic system  
There is evidence, albeit in smaller numbers, that the GABAergic system also modulates the 
recognition of basic emotional expressions. Although benzodiazepines are typical anxiolytic 
drugs, few studies have been carried out so far investigating their effect on the processing of 
facial expressions, and they show seemingly contradictory results. It has been that 15 mg of 
diazepam selectively impair the identification of angry faces (Blair & Curran, 1999). In a 
further study, however, the same research group (Zangara et al., 2002) reported that the 
same dose of diazepam affected both angry and fearful faces. To explain these conflicting 
results, the authors considered that the emotional state of the volunteers could have 
interfered with the processing of emotional cues, since in the former study, the participants 
reported more anxiety and discomfort than in the latter. Another study has pointed to a 
global impairment by diazepam of the identification of emotional faces (Coupland et al., 
2003). There is also reported evidence showing no effect of lorazepam (Kamboj & Curran, 
2006) or of a low dose of diazepam (Murphy et al., 2008) on the recognition of facial 
emotional expressions. 
The discrepancy in results between the studies described above may be due to differences in 
the interval between drug administration and implementation of the experimental 
procedure. In the first (Blair & Curran, 1999) and second (Zangara et al., 2002) studies, the 
task was initiated 40 minutes after ingestion of the drug, while in the third (Coupland et al., 
2003), the task began 75 minutes after drug administration. Therefore, the sedative effects of 
diazepam may have been responsible for a loss of attention and consequent impaired 
performance on the task. In addition, the sample of the third study (Coupand et al., 2003) 
was not balanced by sex, with a majority of women relative to men, which may have 
affected the results, since, as discussed earlier, there is evidence of a sexual dimorphism in 
processing of emotion.  
Although ethanol acts on different neurotransmitter systems, it is known that the 
GABAergic system is heavily influenced by this substance and therefore the effects of acute 
alcohol will be discussed in this session. Alcohol impaired the recognition of emotional 
expressions of anger in women, while men had reduction in the identification of faces of 
anger, fear and disgust (Borrill et al., 1987). These data reinforce two points raised earlier: a) 
the GABAergic system plays an important role in the recognition of emotional expressions 
of anger and b) there is a sexual dimorphism in the recognition of facial expressions. It has 
also been shown that low doses of alcohol increased, while higher doses of alcohol 
decreased the recognition of emotional expressions of happiness by healthy males, 
suggesting a dose-dependent effect of alcohol on the recognition of facial expressions (Kano 
et al., 2003).  
 
5.3 Pharmacological challenges and functional neuroimaging  
The combination of pharmacological challenges with functional magnetic resonance 
imaging (Pharmacological Functional Magnetic Resonance Imaging, pharmaco fMRI) is an 
emerging and promising field of study, which allows the investigation of the effect of drugs 
on cerebral metabolic activity through measures of changes in the BOLD (Blood Oxygen 
Level Dependent) signal. However, few studies have investigated the modulation of 
hemodynamic activation by facial expressions.  
So far, only one study (Paulus et al., 2005) examined the effects of pharmacological 
manipulation with benzodiazepines in neuronal activation, measured by magnetic 
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expressions of fear. Challenges with tryptophan point to the same direction, at least in 
female subjects. Dietary supplementation of tryptophan, and consequent increased 
availability of serotonin, facilitated the recognition of facial expressions of fear, while 
tryptophan depletion impaired the recognition of facial expressions of fear. Acute 
administration of citalopram facilitated the recognition of facial expressions of fear, an effect 
similar to those observed with the supplementation of tryptophan in the diet and the acute 
use of ecstasy and opposite to that observed with the depletion of tryptophan and four days 
after the use of ecstasy. Taken together, these data suggest an increase in serotonin function 
immediately after the acute administration of citalopram.  
However, in a recent published study (Alves-Neto et al., 2010), we have found a 
“depressive” effect of a single dose of escitalopram, the pharmacologically active S-
enantiomer of RS-citalopram. The R-enantiomer has been shown to reduce the effects of the 
S-enantiomer (Sanchez, 2006), probably due to negative allosteric interaction at the level of 
the 5-HT transporter. As result, escitalopram behaves as a highly potent and selective ligand 
of the 5-HT transporter and clinical studies have shown that escitalopram causes few side 
effects and has a relatively fast onset of action (Waugh & Goa, 2003). In a placebo controlled 
crossover design study with healthy male volunteers we have found that a single dose of 
escitalopram facilitated the recognition of sadness and inhibited the recognition of 
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same dose of diazepam affected both angry and fearful faces. To explain these conflicting 
results, the authors considered that the emotional state of the volunteers could have 
interfered with the processing of emotional cues, since in the former study, the participants 
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procedure. In the first (Blair & Curran, 1999) and second (Zangara et al., 2002) studies, the 
task was initiated 40 minutes after ingestion of the drug, while in the third (Coupland et al., 
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the GABAergic system plays an important role in the recognition of emotional expressions 
of anger and b) there is a sexual dimorphism in the recognition of facial expressions. It has 
also been shown that low doses of alcohol increased, while higher doses of alcohol 
decreased the recognition of emotional expressions of happiness by healthy males, 
suggesting a dose-dependent effect of alcohol on the recognition of facial expressions (Kano 
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5.3 Pharmacological challenges and functional neuroimaging  
The combination of pharmacological challenges with functional magnetic resonance 
imaging (Pharmacological Functional Magnetic Resonance Imaging, pharmaco fMRI) is an 
emerging and promising field of study, which allows the investigation of the effect of drugs 
on cerebral metabolic activity through measures of changes in the BOLD (Blood Oxygen 
Level Dependent) signal. However, few studies have investigated the modulation of 
hemodynamic activation by facial expressions.  
So far, only one study (Paulus et al., 2005) examined the effects of pharmacological 
manipulation with benzodiazepines in neuronal activation, measured by magnetic 
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resonance functional, caused by facial expressions of basic emotions. Lorazepam was 
administered orally, at doses of 0.25 mg and 1 mg in 15 healthy volunteers (six women and 
nine men). The paradigm of psychological activation consisted of presenting a target face 
(anger, fear or happiness) at the top of the computer screen, being the volunteers asked to 
paired the emotional expression of the target face with one of the emotional expressions 
presented in other two faces shown in bottom the of the computer screen by pressing the 
right and left of a button box. The control task consisted of matching geometric figures. 
Regardless of the type of emotion, the volunteers showed activation of bilateral amygdala 
and insula during the task of matching facial expressions, compared to the control task. 
Lorazepam attenuated the hemodynamic response of the amygdala and the insula, in a 
dose-dependent way.  
The role of the serotonergic system in the emotional faces processing has been a little more 
investigated through the association of pharmacological challenges and fMRI.  
In an unconscious perception paradigm, where volunteers were asked only to recognize the 
sex of faces during the imaging acquisition, tryptophan depletion in healthy men increased 
amygdala activation in response to fear faces compared with neutral and happy faces, but 
just in individuals with high levels of sensitivity to threat, measured by the BIS/BAS 
(Behavioral Inhibition System / Behavioral Aversive System) scale (Cools et al., 2005). These 
results have been replicated in healthy women, showing a significant correlation between 
sensitivity to threats, as measured by the BIS/BAS scale, and more pronounced activation of 
the amygdala to fearful faces compared to faces of happiness, under the effect of depletion 
of tryptophan (van der Veen et al., 2007). This later study also showed that mood changes 
(depressive symptoms) caused by tryptophan depletion in healthy women with a family 
history of depression was associated with greater impairment in the performance in a task 
of sex categorization of faces with negative facial expressions (fear, sadness and disgust) and 
increased right amygdalar activation to faces of fear.  
The effects of tryptophan depletion were also evaluated in the processing of faces of sadness 
and happiness (Fusar-Poli et al., 2007). Independently of the emotional valence of the face, 
tryptophan depletion attenuated the activations of the right medial/inferior frontal gyrus, 
the posterior cingulate cortex, the occipital and parietal cortex bilaterally, the right 
hippocampus, claustrum and insula. Referring specifically to the amygdala, effects were 
observed only when the emotions were combined and compared with neutral faces. The 
depletion of tryptophan attenuated amygdala response to emotional faces.  
In a paradigm of sex categorization of faces, we found that a low dose of citalopram (7.5 
mg), administered intravenously to healthy male volunteers, attenuated the hemodynamic 
response in right amygdala and right orbitofrontal cortex to aversive faces (anger, disgust 
and fear) compared to neutral faces in healthy men (Del-Ben et al., 2005). In a study  
(Anderson et al., 2007) published latter, we reanalyzed the data evaluating the effects of 
intravenous citalopram on each emotion separately and found that citalopram attenuated 
the activation of the amygdala to faces of fear and disgust, while increased activation of the 
insula to disgust faces. No effects of escitalopram on angry faces have been detected.  
In this study (Anderson et al., 2007), although citalopram has reduced the activation of the 
amygdala to faces of fear and disgust, it occurred in different hemispheres. Possibly this is 
due to the fact that, regardless of treatment, the right amygdala activation was more robust 
to the faces of fear, while the left amygdala signal intensity was higher at the faces of 
disgust. A lateralization of the functions of the amygdala has been suggested; the right 
amygdala is more associated with arousal and the left with cognitive processes (Skuse et al., 
2005). It is possible that the faces of fear have a more immediate emotional salience, while 
the faces of disgust require the engagement of cognitive functions for their processing. 
Another possibility would be differences in the time of habituation to the two types of 
stimuli.   
We also observed that, in contrast to the attenuation of the amygdala, citalopram increased 
the activation of left insula (and on right, at a level below statistical significance), extending 
to the claustrum, to disgusted faces. The anterior insula has connections with the amygdala 
and, along with the ventromedial prefrontal cortex, hypothalamus and periaqueductal gray 
material, is part of a network that modulates the identification and response to threatening 
stimuli. However, in this study, we found activation of posterior portions of the insula, 
which seems to be involved with somatosensory processes and pain. Although not specified 
a priori, citalopram increased the activation of the pulvinar nucleus and occipital cortex, 
suggesting that serotonin can enhance the function of pathways responsible for the 
integration of interoceptive and exteroceptive information.  
Further studies have confirmed the role of antidepressants in the emotional faces 
processing. Healthy volunteers of both sexes were subjected to a treatment for seven days 
with citalopram orally at a dose of 20 mg/day and underwent a paradigm of unconscious 
perception of facial expressions of fear and happiness marked by the presentation of 
emotional faces for 17 milliseconds followed by a neutral face with duration of 167 
milliseconds. The amygdala was established as a priori region of interest; the treatment 
caused an attenuation of the activation in the bilateral amygdala to fearful compared with 
happy faces (Harmer et al., 2006). More recently, the same group has shown that a single 
dose of citalopram, administered orally, attenuated the amygdalar activation to masked 
fearful faces (Murphy et al., 2009). Attenuation of amygdala to emotional faces, assessed by 
a paradigm similar to those used in the lorazepam study (described earlier), has also been 
obtained with escitalopram, given to health volunteers during 21 days (Arce et al., 2008).  
In these neuroimaging studies, effects of the drug in the performance of the tasks performed 
during the acquisition of neuroimaging were not observed. Also there were no changes in 
subjective states, except a reduction in self-reported hostility as measured by the Hostility 
Inventory Buss-Durkee after seven days of use of citalopram.  
Given the role of the amygdala in the early stages of coordinating responses to threatening 
stimuli and the production of emotional states, the effects of citalopram and escitalopram 
suggest a modulatory role of serotonin in this process, consistent with previous studies 
showing serotonergic modulation of the amygdala activation to faces of fear by using 
tryptophan depletion (Cools et al., 2005; van der Veen et al., 2007).  
 
5.4 Combining behavioral data and neuroimaging  
To date, few studies have evaluated the modulation of the hemodynamic response caused 
by facial expressions. In addition, differences in the characteristics of the samples, 
procedures for acquisition, the analysis of images and paradigms activation employees 
become even more complex interpreting and conciliating the results of neuroimaging 
studies.  
The interpretation of the modulatory effects of drugs on the findings of fMRI also has its 
limitations. Increased BOLD signal is considered as an increase rate of neuronal metabolism, 
as measured by oxygen consumption. The increase in neuronal metabolism caused by the 
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hippocampus, claustrum and insula. Referring specifically to the amygdala, effects were 
observed only when the emotions were combined and compared with neutral faces. The 
depletion of tryptophan attenuated amygdala response to emotional faces.  
In a paradigm of sex categorization of faces, we found that a low dose of citalopram (7.5 
mg), administered intravenously to healthy male volunteers, attenuated the hemodynamic 
response in right amygdala and right orbitofrontal cortex to aversive faces (anger, disgust 
and fear) compared to neutral faces in healthy men (Del-Ben et al., 2005). In a study  
(Anderson et al., 2007) published latter, we reanalyzed the data evaluating the effects of 
intravenous citalopram on each emotion separately and found that citalopram attenuated 
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amygdala to faces of fear and disgust, it occurred in different hemispheres. Possibly this is 
due to the fact that, regardless of treatment, the right amygdala activation was more robust 
to the faces of fear, while the left amygdala signal intensity was higher at the faces of 
disgust. A lateralization of the functions of the amygdala has been suggested; the right 
amygdala is more associated with arousal and the left with cognitive processes (Skuse et al., 
2005). It is possible that the faces of fear have a more immediate emotional salience, while 
the faces of disgust require the engagement of cognitive functions for their processing. 
Another possibility would be differences in the time of habituation to the two types of 
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We also observed that, in contrast to the attenuation of the amygdala, citalopram increased 
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material, is part of a network that modulates the identification and response to threatening 
stimuli. However, in this study, we found activation of posterior portions of the insula, 
which seems to be involved with somatosensory processes and pain. Although not specified 
a priori, citalopram increased the activation of the pulvinar nucleus and occipital cortex, 
suggesting that serotonin can enhance the function of pathways responsible for the 
integration of interoceptive and exteroceptive information.  
Further studies have confirmed the role of antidepressants in the emotional faces 
processing. Healthy volunteers of both sexes were subjected to a treatment for seven days 
with citalopram orally at a dose of 20 mg/day and underwent a paradigm of unconscious 
perception of facial expressions of fear and happiness marked by the presentation of 
emotional faces for 17 milliseconds followed by a neutral face with duration of 167 
milliseconds. The amygdala was established as a priori region of interest; the treatment 
caused an attenuation of the activation in the bilateral amygdala to fearful compared with 
happy faces (Harmer et al., 2006). More recently, the same group has shown that a single 
dose of citalopram, administered orally, attenuated the amygdalar activation to masked 
fearful faces (Murphy et al., 2009). Attenuation of amygdala to emotional faces, assessed by 
a paradigm similar to those used in the lorazepam study (described earlier), has also been 
obtained with escitalopram, given to health volunteers during 21 days (Arce et al., 2008).  
In these neuroimaging studies, effects of the drug in the performance of the tasks performed 
during the acquisition of neuroimaging were not observed. Also there were no changes in 
subjective states, except a reduction in self-reported hostility as measured by the Hostility 
Inventory Buss-Durkee after seven days of use of citalopram.  
Given the role of the amygdala in the early stages of coordinating responses to threatening 
stimuli and the production of emotional states, the effects of citalopram and escitalopram 
suggest a modulatory role of serotonin in this process, consistent with previous studies 
showing serotonergic modulation of the amygdala activation to faces of fear by using 
tryptophan depletion (Cools et al., 2005; van der Veen et al., 2007).  
 
5.4 Combining behavioral data and neuroimaging  
To date, few studies have evaluated the modulation of the hemodynamic response caused 
by facial expressions. In addition, differences in the characteristics of the samples, 
procedures for acquisition, the analysis of images and paradigms activation employees 
become even more complex interpreting and conciliating the results of neuroimaging 
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The interpretation of the modulatory effects of drugs on the findings of fMRI also has its 
limitations. Increased BOLD signal is considered as an increase rate of neuronal metabolism, 
as measured by oxygen consumption. The increase in neuronal metabolism caused by the 
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pharmacological challenge may reflect either an increase in performance ("working better") 
or the need for an extra effort to achieve the same level of function ("working harder"). The 
ideal experimental design would be studies correlating behavioral and neuroimaging data 
and taking into account some confounding variables such as dose, route and time of 
administration of the pharmacological challenges, as well as sex, age, personality traits, 
previous history of mental disorders of the participant and his/her relatives and genetics. 
The only study so far carried out with benzodiazepines (Paulus et al., 2005) pointed to the 
attenuation of the amygdala and the insula to emotional faces (positive and positive) 
compared with a sensorimotor task. These data are in line with behavioral data that show an 
impairment of the recognition of emotional faces, particularly anger, caused by 
benzodiazepines (Blair and Curran, 1999; Coupland et al., 2003; Zangara et al., 2002).  
Conciliating the results obtained in both behavioral studies and neuroimaging findings that 
evaluated the serotoninergic function makes the situation even more complex, since the 
direction of the modulation of neuronal activation is contrary to those of the behavioral 
studies. If indeed there is a direct correlation between neuronal activation and performance 
on the task, we would expected that increased serotonergic function would increase 
neuronal activations and vice versa, but the studies carried out so far point to an increase in 
neuronal activation of the amygdala (Cools et al., 2005; van der Veen et al., 2007) and 
reduced accuracy in identifying faces of fear (Harmer et al., 2003b; Marsh et al., 2006) under 
the effect of depletion of tryptophan. Moreover, behavioral studies point to a facilitation, by 
acute citalopram, of the recognition of faces of fear (Harmer et al., 2003a) and neuroimaging 
studies show an attenuation of activation of the amygdala with acute dose (Anderson et al., 
2007; Murphy et al., 2009) and of citalopram, given during 7 days (Harmer et al., 2006), and 
escitalopram, given during 21 days (Arce et al., 2008).  
The effects of tryptophan depletion described above were obtained only in volunteers 
sensitive to threat and therefore these apparently contradictory results may be related to the 
influence of personality traits. As discussed later, clinical studies show a more pronounced 
activation of the amygdala to facial expressions in healthy subjects with high traits of 
anxiety and in patients with anxiety disorders.  
With regard to citalopram, it may be that the route of administration has some influence on 
the effects of drugs on serotonin function. As a part of the study described previously (Del-
Ben et al., 2005) images were taken immediately before, during and immediately after 
infusion of citalopram in order to evaluate the direct effects of the drug in the hemodynamic 
responses. We observed a pattern of activation of neuronal responses in several brain 
structures involved in emotional processing (McKie et al., 2005) similar to those observed 
with the administration of metaclorofenilpiperazina (mCPP), a serotonin agonist (Anderson 
et al., 2002). Therefore, one may speculate that with the intravenous administration, there is 
an initial effect of increased serotonin function, before the activation of inhibitory auto-
receptors. However, the results obtained with a single dose of citalopram, given orally, has 
also shown an attenuation of amygdala to fearful faces (Murphy et al., 2009). 
An alternative explanation for the initial effects of the antidepressants has been proposed by 
Catherine Harmer and her colleagues (Harmer et al., 2009). It has been proposed that the 
clinical effects, particularly in depressed patients, are due to initial changes in the way that 
the individual processes relevant emotional information, correcting the negative emotional 
bias normally observed in these patients, which, in turn, lead to mood changes. According 
to this view, early changes in emotional processing precede and contribute to later changes 
in mood and depressive symptoms following antidepressant drug treatment.  
 
6. Final remarks 
Emotional faces processing is an innate and socially relevant human ability that can easily 
be assessed. It can be under the influence of personality traits, genetics and sexual 
dimorphism, and can be altered by current or past psychiatric diagnosis. Of particular 
interest, it can be manipulated by drugs largely used in the clinical practice. Relatively 
simple paradigms composed by facial expressions of basic emotions have contributed 
significantly for a better understanding of the pathophysiology of several mental disorders. 
This tool can also have a role for different purposes, such as the prediction of the clinical 
response, the discovery of new compounds, among others.   
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